Stero Biotechs
CBD-based Treatment Solutions
StartupStero Biotechs is a Bnei Brak-based startup in the Health Tech & Life Sciences sector, established in 2017. CBD-based Treatment Solutions. The company has raised a total of $1M across 1 funding round, currently at the Seed stage. Stero Biotechs was founded by David Bassa. Key investors include Undisclosed Investor(s). The company has 1-10 employees. Core technologies: Biologicals.
With $1M in total funding, Stero Biotechs is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQBnei Brak
- DistrictCenter District
- Last Round$1M
- Undisclosed Investor(s)
David BassaCEO
14 articles covered by sources including www.prnewswire.com,
www.israel-cannabis.com,
www.israel21c.org,
www.algemeiner.com,
www.globenewswire.com.
What does Stero Biotechs do?
STERO Biotechs is a clinical-stage company that researches and develops novel and improved treatment solutions designed to benefit patients by reducing the side effects of and need for steroid therapy. STERO uses cannabidiol (CBD), a non-psychotropic component of cannabis sativa, which has been shown to possess potent immunomodulatory and anti-inflammatory properties in a variety of indications. The company has commenced several clinical trials, including phase 2a clinical trials for steroid dependent Crohns disease (IBD) in Q1 2020 and for chronic urticaria (hives) in Q3 2020. In addition, STEROs phase 1/2 clinical trial treating patients with severe COVID-19 started in Q1 2021. Additional clinical trials for more indications are in the pipeline for 2021. STERO Biotechs was established in partnership with Mor Research Applications, the technology transfer unit of CLALIT Health Services.
How much funding has Stero Biotechs raised?
Stero Biotechs has raised $1M in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include Undisclosed Investor(s).
Who founded Stero Biotechs?
Stero Biotechs was founded in 2017 by David Bassa (CEO).
What sector is Stero Biotechs in?
Stero Biotechs operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Medical Cannabis, with core technologies in Biologicals. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Stero Biotechs located?
Stero Biotechs is based in Baruch Hirsch Street 14, Bnei Brak, Israel, Center District.